These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 35085734)
1. Magnolol-loaded cholesteryl biguanide conjugate hydrochloride nanoparticles for triple-negative breast cancer therapy. Wang Y; Sun C; Huang L; Liu M; Li L; Wang X; Wang L; Sun S; Xu H; Ma G; Zhang L; Zheng J; Liu H Int J Pharm; 2022 Mar; 615():121509. PubMed ID: 35085734 [TBL] [Abstract][Full Text] [Related]
2. Cancer Cell Membrane Wrapped Nanoparticles for the Delivery of a Bcl-2 Inhibitor to Triple-Negative Breast Cancer. Scully MA; Wilkins DE; Dang MN; Hoover EC; Aboeleneen SB; Day ES Mol Pharm; 2023 Aug; 20(8):3895-3913. PubMed ID: 37459272 [TBL] [Abstract][Full Text] [Related]
3. Dual Functions of Riboflavin-functionalized Poly(lactic-co-glycolic acid) Nanoparticles for Enhanced Drug Delivery Efficiency and Photodynamic Therapy in Triple-negative Breast Cancer Cells. Mekseriwattana W; Phungsom A; Sawasdee K; Wongwienkham P; Kuhakarn C; Chaiyen P; Katewongsa KP Photochem Photobiol; 2021 Nov; 97(6):1548-1557. PubMed ID: 34109623 [TBL] [Abstract][Full Text] [Related]
4. Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer. Wang S; Shao M; Zhong Z; Wang A; Cao J; Lu Y; Wang Y; Zhang J Drug Deliv; 2017 Nov; 24(1):1791-1800. PubMed ID: 29172759 [TBL] [Abstract][Full Text] [Related]
5. Orlistat and antisense-miRNA-loaded PLGA-PEG nanoparticles for enhanced triple negative breast cancer therapy. Bhargava-Shah A; Foygel K; Devulapally R; Paulmurugan R Nanomedicine (Lond); 2016 Feb; 11(3):235-47. PubMed ID: 26787319 [TBL] [Abstract][Full Text] [Related]
6. Biomimetic peptide display from a polymeric nanoparticle surface for targeting and antitumor activity to human triple-negative breast cancer cells. Bressler EM; Kim J; Shmueli RB; Mirando AC; Bazzazi H; Lee E; Popel AS; Pandey NB; Green JJ J Biomed Mater Res A; 2018 Jun; 106(6):1753-1764. PubMed ID: 29424479 [TBL] [Abstract][Full Text] [Related]
7. "Triple-punch" strategy for triple negative breast cancer therapy with minimized drug dosage and improved antitumor efficacy. Su S; Tian Y; Li Y; Ding Y; Ji T; Wu M; Wu Y; Nie G ACS Nano; 2015 Feb; 9(2):1367-78. PubMed ID: 25611071 [TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid engrafted metformin loaded graphene oxide nanoparticle as CD44 targeted anti-cancer therapy for triple negative breast cancer. Basu A; Upadhyay P; Ghosh A; Bose A; Gupta P; Chattopadhyay S; Chattopadhyay D; Adhikary A Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129841. PubMed ID: 33412224 [TBL] [Abstract][Full Text] [Related]
9. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer. He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524 [TBL] [Abstract][Full Text] [Related]
10. Lignin-graft-PLGA drug-delivery system improves efficacy of MEK1/2 inhibitors in triple-negative breast cancer cell line. Byrne CE; Astete CE; Vaithiyanathan M; Melvin AT; Moradipour M; Rankin SE; Knutson BL; Sabliov CM; Martin EC Nanomedicine (Lond); 2020 Apr; 15(10):981-1000. PubMed ID: 32238059 [No Abstract] [Full Text] [Related]
11. Methoxy poly(ethylene glycol)-poly(lactide) nanoparticles encapsulating quercetin act as an effective anticancer agent by inducing apoptosis in breast cancer. Sharma G; Park J; Sharma AR; Jung JS; Kim H; Chakraborty C; Song DK; Lee SS; Nam JS Pharm Res; 2015 Feb; 32(2):723-35. PubMed ID: 25186442 [TBL] [Abstract][Full Text] [Related]
12. Triple negative breast cancer therapy with CDK1 siRNA delivered by cationic lipid assisted PEG-PLA nanoparticles. Liu Y; Zhu YH; Mao CQ; Dou S; Shen S; Tan ZB; Wang J J Control Release; 2014 Oct; 192():114-21. PubMed ID: 25016158 [TBL] [Abstract][Full Text] [Related]
13. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Hadinoto K; Sundaresan A; Cheow WS Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180 [TBL] [Abstract][Full Text] [Related]
15. Delivery of Apoptosis-inducing Piperine to Triple-negative Breast Cancer Cells Rad JG; Hoskin DW Anticancer Res; 2020 Feb; 40(2):689-694. PubMed ID: 32014909 [TBL] [Abstract][Full Text] [Related]
16. Prophylactic and therapeutic potential of magnolol-loaded PLGA-PEG nanoparticles in a chronic murine model of allergic asthma. Wang J; Xian M; Cao H; Wu L; Zhou L; Ma Y; Fan L; Lin L; Li G; Huang Q; Huang SK; Xiao X Front Bioeng Biotechnol; 2023; 11():1182080. PubMed ID: 37214308 [TBL] [Abstract][Full Text] [Related]
17. Enhanced cellular uptake of folic acid-conjugated PLGA-PEG nanoparticles loaded with vincristine sulfate in human breast cancer. Chen J; Li S; Shen Q; He H; Zhang Y Drug Dev Ind Pharm; 2011 Nov; 37(11):1339-46. PubMed ID: 21524153 [TBL] [Abstract][Full Text] [Related]
18. Preparation, characterization and uptake of PEG-coated, muco-inert nanoparticles in HGC-27 cells, a mucin-producing, gastric-cancer cell line. Lin D; Li G; Qin L; Wen Z; Wang J; Sun X J Biomed Nanotechnol; 2013 Dec; 9(12):2017-23. PubMed ID: 24266257 [TBL] [Abstract][Full Text] [Related]
19. Sequential delivery of erlotinib and doxorubicin for enhanced triple negative Breast cancer treatment using polymeric nanoparticle. Zhou Z; Kennell C; Jafari M; Lee JY; Ruiz-Torres SJ; Waltz SE; Lee JH Int J Pharm; 2017 Sep; 530(1-2):300-307. PubMed ID: 28778627 [TBL] [Abstract][Full Text] [Related]
20. ICG/l-Arginine Encapsulated PLGA Nanoparticle-Thermosensitive Hydrogel Hybrid Delivery System for Cascade Cancer Photodynamic-NO Therapy with Promoted Collagen Depletion in Tumor Tissues. Sun Z; Wang X; Liu J; Wang Z; Wang W; Kong D; Leng X Mol Pharm; 2021 Mar; 18(3):928-939. PubMed ID: 33427470 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]